AF
BHVN

Advisornet Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Advisornet Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,108
Closed -$621K – 2548
2022
Q3 		$621K Sell
4,108
-293
-7% -$43.4K 0.06% 279
2022
Q2 		$641K Sell
4,401
-5
-0.1% -$639 0.06% 270
2022
Q1 		$522K Buy
4,406
+70
+2% +$8.73K 0.03% 362
2021
Q4 		$598K Buy
4,336
+2,136
+97% +$272K 0.04% 364
2021
Q3 		$306K Hold
2,200
– – 0.02% 462
2021
Q2 		$214K Buy
+2,200
New +$179K 0.01% 579
2020
Q4 		– Sell
-150
Closed -$10K – 1928
2020
Q3 		$10K Hold
150
– – ﹤0.01% 1288
2020
Q2 		$11K Hold
150
– – ﹤0.01% 1295
2020
Q1 		$5K Buy
+150
New +$6.86K ﹤0.01% 1457

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Advisornet Financial's BHVN Position: Q4 2022 in Review

Advisornet Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 4,108 shares — an estimated $621K sold.

Advisornet Financial first reported a position in BHVN in Q1 2020 and held it in 9 quarters. The position peaked at $641K in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Advisornet Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Advisornet Financial sold 4,108 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $621K.
  • Advisornet Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2020 and held it in 9 quarters.
  • Advisornet Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $641K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Advisornet Financial's 13F filing for Q4 2022, filed 13 Jan 2023.